ECG criteria
- High QRS voltage and/or signs of LV overload in chest leads may be present; Sokolov–Lyon and Cornell criteria have limited sensitivity and are not mandatory for diagnosis
- Deep symmetrical negative T waves in V2–V6, peaking in V3–V5, sometimes of very high amplitude (conventionally "giant" if ≥10 mm, but the threshold is not required for diagnosis)
- ST-segment changes are variable: ST depression (more commonly downsloping/non-horizontal) is possible in the same leads, but its presence and morphology neither confirm nor exclude the diagnosis by themselves and require assessment of the clinical context
- QTc may be normal or altered; QTc prolongation is not a criterion for apical HCM and is not among its characteristic features
- Pathological Q waves are usually absent, but can occur in HCM and do not reliably distinguish it from myocardial infarction; the absence of Q waves and lack of dynamics on serial ECGs do not rule out ACS
- R-wave progression in the chest leads can vary and lacks sufficient diagnostic or differential specificity
- Changes are stable over time on follow-up (unlike ACS evolution), but ECG stability does not rule out ACS and does not replace clinical evaluation
What it looks like on ECG
The typical pattern consists of deep symmetrical negative T waves concentrated in leads V2–V6 and peaking in V3–V5, frequently combined with high QRS voltage in the chest leads. The amplitude of negative T waves is variable and can be very large—hence the conventional term "giant negative T waves," which is usually associated with an amplitude of 10 mm or more, but this is a descriptive concept rather than a mandatory diagnostic threshold. High voltage and formal LVH criteria (Sokolov–Lyon, Cornell) are common but not required: the ECG may demonstrate predominantly giant negative T waves without definite voltage criteria for LVH.
In the same leads, ST-segment changes are inconstant: ST depression is sometimes visible, usually shallow, downsloping, without the typical convex elevation seen in STEMI; however, the depression itself is neither a reliable nor a mandatory sign and does not replace the assessment of the clinical picture when ischemia is suspected.
| Sign | Typical localization |
|---|---|
| High R wave (not mandatory) | V3–V5 |
| Deep negative T wave | V3–V5, sometimes extending to V6 and II, III, aVF |
| ST depression | possible in the same leads, inconstant |
| QTc | variable, not characteristic as a typical sign |
Pathological Q waves are typically absent, but may also occur in HCM itself, so their absence does not reliably rule out prior myocardial infarction. The cardiac axis may be normal. In limb leads, T-wave changes are usually less pronounced than in chest leads. The pattern often persists for months and years on repeated recordings, which distinguishes it from the dynamically changing ECG in acute coronary syndrome, but this observation does not replace clinical examination when ACS is suspected.
Mechanism
The underlying mechanism is primarily apical hypertrophy of the left ventricular myocardium. This phenotype often occurs without LV outflow tract obstruction; however, LVOT obstruction or mid-ventricular obstruction may coexist with the apical variant of hypertrophy, and in some cases, an apical cavity with an apical aneurysm is formed. The hypertrophied and structurally altered apical myocardium is accompanied by a disruption in the normal sequence and homogeneity of repolarization in this zone. These changes are recorded on the surface ECG as deep T-wave inversion in leads "facing" the apex—chest leads V2–V6. The exact electrophysiological mechanism of T-wave inversion is complex and not reducible to a single proven repolarization vector direction; it is more accurately described as a consequence of altered electrophysiological properties of the hypertrophied myocardium rather than as a definitively established phenomenon. High QRS voltage, when present, reflects increased left ventricular muscle mass, as in any hypertrophy.
Causes
- Genetically determined hypertrophic cardiomyopathy (sarcomeric protein gene mutations) is a frequent cause, including in Western populations
- The apical phenotype is more commonly described in East Asian populations (historically described in Japan, hence Yamaguchi syndrome); the genetic substrate may be sarcomeric, but in many patients, a causative variant is not identified
- Sometimes combined with other forms of HCM (mixed hypertrophy)
Differential diagnosis
- Non-ST-segment elevation ACS / myocardial ischemia — apical HCM can mimic ischemic changes, but the lack of dynamics on serial ECGs, absence of typical chest pain, or normal troponin do not rule out ACS by themselves: early troponin may be negative and pain atypical. When ACS is clinically suspected, patients are evaluated and managed according to the relevant validated algorithm (serial ECGs, serial troponins), and the diagnosis of apical HCM is confirmed by imaging, not by the absence of these signs
- Wellens' syndrome — negative/biphasic T waves in V2–V3, a sign of critical stenosis of the left anterior descending artery. Changes may persist between pain episodes and be relatively stable on repeat ECGs, so pattern stability does not reliably distinguish Wellens' from apical HCM. When this pattern is suspected, urgent evaluation excluding ACS is required: pain history, serial ECGs and troponins, coronary evaluation
- LV overload/hypertrophy of other etiology (hypertensive heart disease) — can also be accompanied by marked repolarization changes up to deep negative T waves; T-wave amplitude and QRS axis direction are not reliable differentiating features. Differentiation is based on history (hypertension, duration, other causes of hypertrophy) and imaging data
- Posterior/lateral myocardial infarction — evaluated using serial ECGs, including additional leads V7–V9 when posterior localization is suspected, reciprocal changes (ST depression in V1–V3), symptoms, and serial high-sensitivity troponins; pathological Q waves in apical HCM are usually absent, but their absence alone does not rule out infarction
- Takotsubo cardiomyopathy — acute onset, often following stress, deep T waves and prolonged QT, but changes are transient, resolving within weeks; apical HCM is a chronic finding
Imaging helps definitively differentiate: echocardiography or cardiac MRI, which shows characteristic apical thickening and an "ace-of-spades" left ventricular cavity configuration on ventriculography.
Clinical significance and management
Apical HCM generally has a more favorable course than the obstructive form of hypertrophic cardiomyopathy, but carries risks common to HCM: atrial fibrillation, ventricular arrhythmias, formation of an apical aneurysm with a risk of thromboembolism, and, rarely, sudden cardiac death. When acute coronary syndrome is suspected, clinical evaluation, serial ECGs, and troponins according to the standard algorithm are performed in all cases, regardless of the suspected diagnosis of HCM, and ACS treatment is not delayed while waiting for imaging. If this evaluation rules out acute ischemia and the ECG pattern suggests apical HCM, the patient is referred for echocardiography with targeted assessment of the left ventricular apex; if apical visualization is suboptimal or results are inconclusive, cardiac MRI with contrast is performed if necessary. Imaging assesses apical myocardial thickness, presence of aneurysm, and systolic function. Further follow-up includes sudden death risk stratification using general HCM criteria, and Holter monitoring to detect ventricular arrhythmias. In confirmed HCM, clinical screening of first-degree relatives is performed (ECG and echocardiography with periodic repeats); genetic testing is used if an informative pathogenic variant is present in the family.
Common interpretation errors
- Interpreting stable ECG changes, absence of typical pain, or normal troponin as signs that definitively rule out ACS
- Confusion with Wellens' syndrome due to similar localization of changes in the anterior chest leads and erroneous use of ECG stability as a differentiating criterion
- Reliance on obligatory high QRS voltage: its absence does not rule out apical HCM
- Omission of imaging studies in the presence of a characteristic ECG pattern, which delays diagnosis
- Presenting QTc prolongation, ST depression, or preserved R-wave progression as mandatory or specific signs of apical HCM
1. Which ECG sign is most characteristic of apical hypertrophic cardiomyopathy?
Deep symmetrical negative T waves in the anterior chest leads are the most characteristic, yet non-specific sign of apical HCM; they also occur in ischemia, Wellens' syndrome, and Takotsubo cardiomyopathy, which is why the diagnosis is confirmed by imaging and clinical evaluation.
2. Why does the stability of T-wave changes on serial ECGs not reliably differentiate apical HCM from Wellens' syndrome?
T-wave changes in Wellens' syndrome may remain stable in the absence of pain, so a static picture is not a reliable exclusion criterion and requires ruling out ACS urgently.
3. Which method confirms the diagnosis of apical HCM in the presence of a characteristic ECG pattern?
The diagnosis is confirmed by imaging — echocardiography or MRI, which demonstrates the characteristic hypertrophy of the left ventricular apex.
Frequently asked questions
How to differentiate apical HCM from myocardial ischemia on the ECG?
The persistence of deep negative T waves in chest leads across repeated tracings over months and years supports a chronic etiology, but does not rule out ACS on its own. When clinical suspicion of ischemia exists, symptoms must be evaluated, serial ECGs performed, and troponins checked according to the standard algorithm. The diagnosis of apical HCM is confirmed by imaging — echocardiography or cardiac MRI showing characteristic apical hypertrophy.
Is apical hypertrophic cardiomyopathy dangerous?
The clinical course is generally more favorable than in obstructive HCM, but risks remain for atrial fibrillation, ventricular arrhythmias, apical aneurysm formation with thromboembolism, and, rarely, sudden cardiac death. Cardiologist follow-up and risk stratification according to general HCM criteria are required.
Why is apical HCM referred to as Yamaguchi syndrome?
This variant of hypertrophic cardiomyopathy was first described in detail by Japanese researchers, in whom it is more prevalent than in Western populations. Hence the established eponym «Yamaguchi syndrome».
What ECG changes are characteristic of apical HCM?
Deep symmetrical negative T waves in the chest leads, maximally pronounced in V3–V5, occasionally combined with high QRS voltage. ST depression, QTc alterations, and the presence or absence of a pathological Q wave may occur, but are not mandatory or reliable diagnostic signs.
Is coronary angiography necessary when apical HCM is suspected?
Decision-making relies on clinical evaluation rather than a suspected diagnosis of HCM: if ACS is reasonably suspected, workup and management follow the standard algorithm, including an invasive strategy when indicated. If acute ischemia is ruled out, the next step to confirm apical HCM is cardiac imaging — echocardiography, with MRI if necessary.
ECG Course
Interpretation from basics to myocardial infarction — learn to read any ECG using a systematic algorithm.
- Video lessons and theory for every topic
- Simulator case studies under every lesson
- Unlimited ECG simulator practice
- Study guide: "All ECGs in 25 minutes"
ECG Strip Simulator
ECG, radiology, histology, pathomorphology, pharmacology — thousands of flashcards with detailed explanations.
- Real ECG strips, not textbook drawings
- Instant answers and explanations
- Streaks and progress tracking in your dashboard
Related terms
More in the «Channelopathies and Cardiomyopathies» section
Sources
- Hampton J. The ECG in Practice
- Surawicz B., Knilans T. Chou's Electrocardiography in Clinical Practice
- Orlov V.N. Guide to Electrocardiography
Educational material for medical students and physicians. Does not replace clinical guidelines and physical examination; the ECG must always be interpreted in conjunction with the clinical picture.